John Varian
Directeur/Membre du Conseil chez SELLAS LIFE SCIENCES GROUP, INC.
Fortune : 5 236 $ au 30/06/2024
Postes actifs de John Varian
Sociétés | Poste | Début | Fin |
---|---|---|---|
SELLAS LIFE SCIENCES GROUP, INC. | Directeur/Membre du Conseil | 29/12/2017 | - |
Independent Dir/Board Member | 29/12/2017 | - | |
ACORDA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2022 | - |
Independent Dir/Board Member | 01/01/2022 | - | |
AmMax Bio, Inc.
AmMax Bio, Inc. BiotechnologyHealth Technology AmMax Bio, Inc. is a clinical stage biotech company. The private company is based in Redwood City, CA. The CEO of the company is Chung Chiang Hsu. | Directeur/Membre du Conseil | - | - |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Directeur/Membre du Conseil | 29/12/2017 | - |
The Bay Area
The Bay Area BiotechnologyHealth Technology The Bay Area provides biomedical advocacy services. The private company is based in San Francisco, CA. | Corporate Officer/Principal | - | - |
Historique de carrière de John Varian
Anciens postes connus de John Varian
Sociétés | Poste | Début | Fin |
---|---|---|---|
ZYLA LIFE SCIENCES | Directeur/Membre du Conseil | 07/06/2018 | 01/02/2019 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 01/03/2014 | 12/10/2018 |
Independent Dir/Board Member | 01/03/2014 | 12/10/2018 | |
XOMA ROYALTY CORPORATION | Directeur/Membre du Conseil | 01/12/2008 | 01/05/2017 |
Directeur Général | 31/08/2011 | 21/12/2016 | |
ARYX THERAPEUTICS, INC. | Directeur des opérations | 01/12/2003 | 01/08/2011 |
Directeur Financier/CFO | 01/12/2003 | 01/08/2011 | |
░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | - | ░░░░░░░░░░ | |
░░░ ░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░ ░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░ | - | - |
Formation de John Varian
Western Michigan University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 16 |
Canada | 2 |
Italie | 2 |
Opérationnelle
Director/Board Member | 8 |
Director of Finance/CFO | 7 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 15 |
Commercial Services | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
ARYX THERAPEUTICS, INC. | Health Technology |
XOMA ROYALTY CORPORATION | Health Technology |
SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
ACORDA THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 14 |
---|---|
Neurex Corp.
Neurex Corp. Pharmaceuticals: MajorHealth Technology Neurex Corporation is a developmental biopharmaceutical company focused on acute care therapeutics for the treatment of diverse neurological and cardiovascular indications. | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
The Bay Area
The Bay Area BiotechnologyHealth Technology The Bay Area provides biomedical advocacy services. The private company is based in San Francisco, CA. | Health Technology |
Gen Set SpA
Gen Set SpA Electrical ProductsProducer Manufacturing Gen Set SpA manufactures portable generators. Its products include industrail generators, special applications, welding, veicolar generators, and light towers. The company was founded by Pascal Brandys in 1974 and is headquartered in Villanova d'Ardenghi, Italy. | Producer Manufacturing |
Anergen, Inc. | Health Technology |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
SELLAS Life Sciences Group, Inc. /Old/
SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology SELLAS Life Sciences Group, Inc. /Old/ is based in New York, NY. SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. | Health Technology |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
Zyla Life Sciences LLC
Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
AmMax Bio, Inc.
AmMax Bio, Inc. BiotechnologyHealth Technology AmMax Bio, Inc. is a clinical stage biotech company. The private company is based in Redwood City, CA. The CEO of the company is Chung Chiang Hsu. | Health Technology |
- Bourse
- Insiders
- John Varian
- Expérience